市場調查報告書
商品編碼
1390848
奈米孔技術市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測Nanopore Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球奈米孔技術市場規模達2.444億美元。展望未來, IMARC Group預計到2028年市場規模將達到5.115億美元,2022-2028年複合年成長率(CAGR)為13.10%。
奈米孔技術是指無需對樣本進行聚合酶鍊式反應(PCR)擴增和化學標記的單分子脫氧核糖核酸(DNA)的新一代分子定序。它提供相對高的通量和低成本的基因分型、測試的高移動性、即時快速處理樣品以及無標記的超長讀取。它用作診斷工具,提供快速分析、消除繁瑣的擴增和轉換步驟、檢測極低濃度的目標分子以及篩選生物標記或基因組。如今,由於先進的奈米孔蛋白質和化學物質的引入,奈米孔技術的讀取品質已顯著提高。
冠狀病毒病(COVID-19)的爆發,加上開發潛在治療方法的迫切需要,是推動全球奈米孔技術需求的關鍵因素之一。研究人員廣泛依賴這些技術來產生資料,從病毒基因組的初步表徵到變種的快速識別,這對於對抗疫情的傳播至關重要。除此之外,由於吸菸、飲酒、肥胖和慢性發炎的人數不斷增加,很大一部分人口中癌症盛行率不斷上升,這也促進了市場的成長。奈米孔技術用於腫瘤學領域,透過檢測和準確定量 microRNA 來促進癌症診斷和治療。此外,領先的市場參與者正在推出新一代感測技術,該技術利用嵌入高科技電子產品中的奈米孔來執行精確的分子分析。這項技術在臨床診斷、流行病學、食品安全、農業和環境科學等應用領域已被廣泛採用。預計此類創新將對市場產生正面影響。
The global nanopore technologies market size reached US$ 244.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 511.5 Million by 2028, exhibiting a growth rate (CAGR) of 13.10% during 2022-2028.
Nanopore technology refers to the next-generation molecule sequencing of single-molecule deoxyribonucleic acid (DNA) without the need for polymerase chain reaction (PCR) amplification and chemical labeling of the sample. It offers a relatively high throughput and low-cost genotyping, high mobility for testing, rapid processing of samples in real-time, and label-free, ultralong reads. It is used as a diagnostic tool to provide a fast analysis, eliminate cumbersome amplification and conversion steps, and detect target molecules at very low concentrations and screen panels of biomarkers or genes. Nowadays, the read quality of nanopore technology has improved significantly on account of the introduction of advanced nanopore proteins and chemistries.
The outbreak of the coronavirus disease (COVID-19), in confluence with the urgent need to develop a potential treatment, represents one of the key factors driving the need for nanopore technologies worldwide. Researchers are extensively relying on these technologies to generate data, ranging from initial characterization of the virus genome to the rapid identification of variants, essential to combating the spread of the pandemic. Apart from this, the increasing prevalence of cancer among a significant part of the population due to the rising number of individuals who smoke, drink, and have obesity and chronic inflammation is contributing to the market growth. Nanopore technologies are used in oncology settings for facilitating cancer diagnosis and treatment through the detection and accurate quantification of microRNA. In addition, leading market players are introducing a new generation of sensing technology that uses nanopores embedded in high-tech electronics to perform precise molecular analyses. This technology is gaining widespread adoption in applied settings, such as clinical diagnostics, epidemiology, food safety, agriculture, and environmental science. Such innovations are projected to influence the market positively.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nanopore technologies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.
Instruments
Portable
Benchtop
Consumables
DNA Sequencing
RNA Sequencing
Others
Hospitals and Clinics
Research Institutes
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Cyclomics BV, Electronic Biosciences Inc., Inanobio Inc., Nabsys Inc., Ontera Inc., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., Quantapore Inc., Roche Holding AG and Tracxn Technologies Limited.